Abstract:Object. One hundred seventy-two children with high-grade astrocytomas were treated by members of the Children's Cancer Group in a prospective randomized trial designed to evaluate the role of two chemotherapy regimens. Seventy-six percent of the patients (131 children) in whom a diagnosis of either anaplastic astrocytoma or glioblastoma multiforme was confirmed by central pathological review are the subject of this report. Methods. Patients were stratified according to the extent of tumor resection (biopsy [< 10%], partial resection [10–50%], subtotal resection [51–90%], near-total resection [> 90%], and total resection) as determined by surgical observation and postoperative computerized tomography scanning. Information on contemporary neurosurgical management was obtained from the patient's operative records and standardized neurosurgical report forms. The vast majority of tumors were supratentorial: 63% (83 tumors) in the superficial cerebral hemisphere, 28% (37 tumors) in the deep or midline cerebrum, and only 8% (11 tumors) in the posterior fossa. A significant association was detected between the primary tumor site and the extent of resection (p < 0.0001). A radical resection (> 90%) was performed in 37% of the children: 49% of the tumors in the superficial hemisphere and 45% of tumors in the posterior fossa compared with 8% of midline tumors. Tumor location could also be used to predict the need for both temporary and permanent cerebrospinal fluid (CSF) diversion. Half of the deep tumors and 8% of the hemispheric astrocytomas ultimately required a permanent CSF shunt. Improvement in preoperative neurological deficits and level of consciousness was seen in 36% and 34% of the children, respectively. New or increased deficits were present in 14% of the children, with 6% experiencing a diminished sensorium after surgery. Postoperative nonneurological complications were rare: infection, hematoma, and CSF fistula each occurred in 1.7% of the children. Univariate and multivariate analyses demonstrated that radical tumor resection (> 90%) was the only therapeutic variable that significantly improved progression-free survival (PFS) rates. For all patients with malignant astrocytomas, the distributions of PFS rates were significantly different (p = 0.006) following radical resection compared with less extensive (< 90%) resection. The 5-year PFS rates were 35 ± 7% and 17 ± 4%, respectively. The differences in the distribution of PFS rate were significant for the subsets of patients with anaplastic astrocytoma (p = 0.055) and glioblastoma multiforme (p = 0.046). The 5-year PFS rates for anaplastic astrocytoma were 44 ± 11% and 22 ± 6% for cases in which the tumor was radically resected and less than radically resected, respectively; whereas the 5-year PFS rates for glioblastoma multiforme were 26 ± 9% and 4 ± 3% for cases in which the tumor was radically resected and less than radically resected, respectively. Conclusions. The demonstration of a survival advantage provided by radical resection should prompt neurosurgeons to treat malignant pediatric astrocytomas with aggressive surgical resection prior to initiation of radiotherapy or adjuvant chemotherapy.

Pediatric supratentorial glioblastoma : clinico-pathological features and influencing factors of the outcome

CTNI-36. TREATMENT AND PROGNOSTIC FACTORS FOR PEDIATRIC GLIOBLASTOMAS--THE 10 YEARS EXPERIENCE FROM ONE SINGLE CENTER

HGG-14. TREATMENT AND PROGNOSTIC FACTORS FOR PEDIATRIC GLIOBLASTOMAS--THE 10 YEARS EXPERIENCE FROM ONE SINGLE CENTER

Analysis of Clinical Characteristics and Curative Effect in Pediatric Intracranial Gliomas: Report of 108 Cases

Primary Cerebellar Glioblastomas in Children: Clinical Presentation and Management

[Clinicopathological and molecular characteristics of pediatric gliomas: analysis of 111 cases]

Surgical Treatment and Prognosis of Focal Brainstem Gliomas in Children

Predictors Of Long-Term Survival Following Postoperative Radiochemotherapy For Pathologically Confirmed Suprasellar Germ Cell Tumors

Current Neurosurgical Management and the Impact of the Extent of Resection in the Treatment of Malignant Gliomas of Childhood: a Report of the Children's Cancer Group Trial No. CCG-945

Giant Pediatric Supratentorial Tumor: Clinical Feature and Surgical Strategy

Pediatric Glioma Outcomes: Predictors of Early Mortality

Clinical features and prognostic factor analysis of primary spinal cord glioblastomas

Clinical Features and Outcomes of Primary Spinal Cord Glioblastoma: A Single-Center Experience and Literature Review.

Clinical Factors Influencing Survival Prognosis in Patients with Malignant Glioma

Related Factors Influencing the Progression and Prognosis of Supratentorial Grade Ⅱ Gliomas (a Report of 65 Cases)

The Prognosis of Glioblastoma: a Large, Multifactorial Study.

The Epidemiological Characteristics and Prognostic Factors of Low-Grade Brainstem Glioma: A Real-World Study of Pediatric and Adult Patients

The Treatment and Prognosis of Primary Pediatric Intracranial Nongerminomatous Malignant Germ Cell Tumors

Pediatric Basal Ganglia Region Tumors: Clinical and Radiologic Features Correlated with Histopathologic Findings

Pediatric Meningiomas: 10-Year Experience with 39 Patients

[A Clinical and Molecular Study of Long-Term Survival Glioblastomas].